GHAPPcast

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
  • 5,0 (1)
  • Y HỌC

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).   Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

  1. 5 NGÀY TRƯỚC

    APP Insight: How Do You Develop a Treatment Plan for IBS-C? What Are Some Considerations?

    Thank you Ardelyx for your support on this APP Insight video module. In this video, Amy Ladewski, PA-C, a physician assistant at Northwestern Memorial Hospital in Chicago, shares expert insights on how to develop a personalized treatment plan for irritable bowel syndrome with constipation (IBS-C). Amy explains why a one-size-fits-all approach doesn’t work, emphasizing the importance of reviewing each patient’s medical and psychosocial history, prior therapies, and most bothersome symptoms—whether constipation, abdominal pain, bloating, or distension. She highlights the role of FDA-approved therapies, gut-directed behavioral interventions such as cognitive behavioral therapy and hypnotherapy, as well as dietary strategies like the low FODMAP diet in optimizing care. Amy also stresses the importance of health literacy, insurance access, and collaboration with GI dietitians to ensure patients understand and can apply their treatment plan. For those with overlapping functional defecatory disorders, she underscores the value of diagnostic testing and pelvic floor physical therapy to achieve better outcomes. This holistic, individualized approach empowers patients with IBS-C to improve both bowel function and overall quality of life. For additional educational resources, visit GHAPP.org and the GHAPP ACE App. #IBSC #IrritableBowelSyndrome #Gastroenterology #DigestiveHealth #GutHealth #GIHealth #IBSConstipation #IBSManagement #PatientEducation

    5 phút

  2. 22 THG 10

    GHAPPcast: IBS-C Therapies Explained: Helping Patients Understand Their Options

    Thank you Ardelyx for your support on this podcast episode. In this podcast, Gabriella McCarty, NP, and Kimberly Orleck, PA-C, dive into the complexities of irritable bowel syndrome with constipation (IBS-C) and the wide range of therapies available to help patients. They discuss the importance of taking a thorough patient history to understand whether the primary symptom is constipation, bloating, abdominal pain, or overflow diarrhea—emphasizing that IBS-C treatment is not one-size-fits-all. Gabriella and Kim break down the differences between over-the-counter therapies like fiber and osmotic laxatives, which often help with bowel movements but do little for abdominal pain, and FDA-approved prescription options that also address visceral hypersensitivity, bloating, and global IBS symptoms. They explain how secretagogues and retenagogues work, set realistic expectations around therapy timelines, and highlight the importance of preparing patients for possible side effects such as diarrhea or nausea. By focusing on patient education, shared decision-making, and scheduled follow-up visits, they empower patients to better understand their condition and stay engaged in their care. This conversation provides practical guidance for both GI providers and patients navigating IBS-C management. For more educational resources, visit GHAPP.org and download the GHAPP ACE App. #IBSC #IrritableBowelSyndrome #Gastroenterology #DigestiveHealth #GutHealth #GIHealth #IBSManagement #IBSConstipation #PatientEducation #GHAPPcast

    10 phút

  3. 16 THG 10

    GHAPPcast: Smarter Surveillance: The Rise of Algorithms like GALAD and Their Path to Practice

    Thank you Fujifilm for your support on this podcast episode. In this episode of GHAPPcast, the official podcast of Gastroenterology and Hepatology Advanced Practice Providers, host Samantha Ramirez, NP-C is joined by Tracy Licari, PA-C to explore the rise of biomarker-based algorithms like GALAD in the surveillance of hepatocellular carcinoma (HCC). With more than 25 years of hepatology experience, Tracy shares insights on how combining biomarkers such as AFP, AFP-L3, and DCP with demographic factors like age and gender can improve diagnostic accuracy, risk stratification, and early detection compared to AFP alone. The discussion highlights how GALAD has consistently demonstrated higher accuracy in retrospective studies, the importance of ongoing prospective validation, and the potential for these algorithms to reshape surveillance, treatment response monitoring, and post-transplant risk assessment. Samantha and Tracy also provide practical ways for clinicians to explain complex biomarker concepts to patients without overwhelming them, reinforcing the importance of education and shared decision-making in liver cancer care. This episode delivers actionable insights for APPs, hepatologists, and GI clinicians seeking to stay ahead in the evolving landscape of biomarker-driven surveillance.

    7 phút

  4. 14 THG 10

    FAQ: What is the importance of biomarkers such as fecal calprotectin and CRP?

    In this educational discussion, Mikhail Alper, PA-C, from Fresno, California, highlights the critical role of biomarkers like fecal calprotectin and C-reactive protein (CRP) in managing inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. He explains how these biomarkers provide objective measures of inflammation and treatment response—often revealing more than patient-reported symptoms alone. Michael outlines a practical monitoring timeline, recommending assessment at six weeks to gauge early symptom improvement, followed by biomarker testing at 12 weeks, and endoscopic evaluation at six months to confirm mucosal healing. He also notes the growing value of intestinal ultrasound, though access remains limited in some regions. This video underscores why integrating biomarker monitoring into IBD management is essential for optimizing therapy and improving patient outcomes.

    2 phút

  5. 8 THG 10

    FAQ: What Are the Next Steps When a Patient Still Has Active Disease When Taking Advanced Therapy?

    Thank you AbbVie for your support of this FAQ Video Module. In this educational video, Alison Krustapentus, NP-C from Beth Israel Deaconess Medical Center in Boston discusses how to approach persistent inflammation in patients with inflammatory bowel disease (IBD). She outlines a step-by-step process for confirming true disease activity using objective measures such as C-reactive protein (CRP), fecal calprotectin, cross-sectional imaging, and endoscopy. Alison also explains the role of therapeutic drug monitoring in optimizing anti-TNF therapy, including how to interpret trough levels and antibody testing to guide dose escalation or frequency adjustments. When drug levels are adequate but inflammation persists, she discusses switching mechanisms of action—from anti-TNF agents to IL-23 inhibitors, JAK inhibitors, or vedolizumab—to regain control of disease activity. This video helps clinicians distinguish between primary non-response and secondary loss of response, emphasizing the importance of tracking biomarkers and imaging over time to make informed treatment decisions.

    3 phút

  6. 6 THG 10

    APP Roundtable: Community Resources and Support Systems for CHB

    In this episode, nurse practitioners Chantil Jeffreys, FNP, from Gastro One in Memphis, and Tuesday Werner, DNP, from Mayo Clinic Arizona, explore the vital role of community resources in supporting patients living with chronic hepatitis B. Drawing on over four decades of combined experience in hepatology and transplant medicine, they discuss practical ways clinicians can help patients connect with local and national support systems—from free screening and vaccination programs to educational workshops, mental health counseling, and advocacy initiatives. The conversation highlights trusted organizations such as the Hepatitis B Foundation, American Liver Foundation, and the CDC Hepatitis B Information Center, along with culturally sensitive programs like Asian Pacific Community in Action and 211 Arizona. Listeners will learn how education, early intervention, and advocacy can combat stigma, empower patients, and improve long-term outcomes.

    18 phút

  7. 2 THG 10

    APP Insight: Conducting Meaningful Conversations to Assess Therapy Impact

    In this video, Amy Ladewski, PA-C, a physician assistant at Northwestern Memorial Hospital in Chicago, shares her expertise on having focused and meaningful conversations with patients living with irritable bowel syndrome with constipation (IBS-C) and other neurogastromotility disorders. Amy emphasizes the importance of building rapport, using a patient-centered approach, and assessing not only bowel habits but also quality of life outcomes—from the ability to work and attend school to participating in family and social activities without being limited by symptoms. She explains how to use tools like the Bristol Stool Scale, evaluate stool frequency and evacuation, and ask targeted questions about abdominal pain, bloating, and distension to determine whether current therapies are effective. Amy also highlights the need to monitor side effects, ensure predictability of treatment, and adjust therapies when symptoms remain uncontrolled. With several FDA-approved therapies available for IBS-C, patients do not need to settle for ongoing discomfort. This discussion provides clinicians with practical strategies to guide therapy decisions and empowers patients to seek treatments that truly improve their daily lives. For more educational resources, visit GHAPP.org and the GHAPP ACE App.

    4 phút

  8. 1 THG 10

    GHAPPcast: Decoding Diagnostics: Why Biomarker Development Phases Are Your Clinical Ally

    In this episode of the GHAPPcast, Patrick Horne, NP and Chris Lovell, CRNP discuss the critical role of biomarkers in hepatology and liver disease management. They explain what biomarkers are, how they are used in clinical practice to detect conditions such as hepatocellular carcinoma (HCC), and how they can measure treatment response. The conversation explores the rigorous biomarker development and validation process, beginning with discovery and assay development, through retrospective and prospective validation, and ultimately assessing population impact. Patrick and Chris highlight the role of the Early Detection Research Network (EDRN), established by the National Cancer Institute, in ensuring biomarkers meet strict scientific standards before clinical application. They also emphasize why it is important for clinicians to understand these processes—so they can have greater confidence in applying biomarkers to improve early detection and patient outcomes. This discussion offers a clear, evidence-based perspective on how biomarkers shape the future of liver disease diagnosis and care.

    6 phút
Xem tất cả (119)

Giới Thiệu

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).   Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

Thông Tin

  • Nhà sáng tạo
    Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
  • Năm hoạt động
    2023 - 2025
  • Tập
    119
  • Xếp hạng
    Sạch
  • Bản quyền
    © 2025 GHAPPcast
  • Trang web chương trình
    GHAPPcast

Có Thể Bạn Cũng Thích